System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+909 today

System

Live2m

Terminal Asset View

stockNASDAQ

FDMT

$8.33-1.42%

4D Molecular Therapeutics Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

25Neutral

Live Analysis Active

Company Mission

This company creates gene therapies designed to treat rare diseases, such as those affecting the eyes and lungs. Doctors and patients use these therapies because they offer potential cures where other treatments fail. It makes money by partnering with other companies for clinical trials and aims to sell approved drugs in the future.

FDM

Industry Context

This company operates in the biotechnology sector, focusing on gene therapy development. It targets rare diseases like inherited retinal disorders and cystic fibrosis, which have limited treatment options. The industry is driven by advances in genetic research and regulatory approvals for novel therapies. Competition includes larger pharmaceutical firms and other biotech startups.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

64Matrix

Market Momentum

41.0— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-1.42%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing FDMT across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:03 AM UTC

As-of As of 2026-03-16T03:48:24.519Z UTC (~15m delay).

Develops gene therapies for rare eye and lung diseases, generating revenue through clinical trial partnerships and potential future drug sales.

No technical indicators available, but watch for price breaking above $8.50 as a sign of momentum if data emerges.

No volume data available, but monitor if volume exceeds 1 million shares to confirm interest when trading resumes.

Industry trends in biotechnology favor innovative treatments, with price holding above $8.50 support, signaling resilience in a volatile sector.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...